High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients

The seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined among 105 healthcare workers (HCWs) exposed to four patients who were laboratory confirmed with coronavirus disease 2019 (COVID-19), the disease caused by SARS-CoV-2 infection. These HCWs were immediately...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infection Vol. 81; no. 3; pp. 420 - 426
Main Authors Chen, Yuxin, Tong, Xin, Wang, Jian, Huang, Weijin, Yin, Shengxia, Huang, Rui, Yang, Hailong, Chen, Yong, Huang, Aijun, Liu, Yong, Chen, Yan, Yuan, Ling, Yan, Xiaomin, Shen, Han, Wu, Chao
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.09.2020
The British Infection Association. Published by Elsevier Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was examined among 105 healthcare workers (HCWs) exposed to four patients who were laboratory confirmed with coronavirus disease 2019 (COVID-19), the disease caused by SARS-CoV-2 infection. These HCWs were immediately under quarantine for 14 days as soon as they were identified as close contacts. The nasopharyngeal swab samples were collected on the first and 14th day of the quarantine, while the serum samples were obtained on the 14th day of the quarantine. With the assay of enzyme immunoassay (EIA) and microneutralization assay, 17.14% (18/105) of HCWs were seropositive, while their swab samples were found to be SARS-CoV-2 RNA negative. Risk analysis revealed that wearing face mask could reduce the infection risk (odds ratio [OR], 0.127, 95% confidence interval [CI] 0.017, 0.968), while when exposed to COVID-19 patients, doctors might have higher risk of seroconversion (OR, 346.837, 95% CI 8.924, 13479.434), compared with HCWs exposed to colleagues as well as nurses and general service assistants who exposed to patients. Our study revealed that the serological testing is useful for the identification of asymptomatic or subclinical infection of SARS-CoV-2 among close contacts with COVID-19 patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ISSN:0163-4453
1532-2742
DOI:10.1016/j.jinf.2020.05.067